Companies / Immuto Scientific
Immuto Scientific
Cambridge, Massachusetts, United States
Immuto Scientific analyzes surface protein structures to pinpoint targets for novel therapeutics, particularly for cancer treatment.
Immuto Scientific, based in Cambridge, Massachusetts, United States, has 2 investors on file, among them Gravity Fund and Great Oaks Venture Capital. Its latest round on record is Seed, 18 Sept 2025.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Gravity Fund
18 companies on its checked portfolioIts portfolio leans to Crypto & Web3 (41%), Healthcare & Biotech (35%), AI & Machine Learning (24%).
More from Great Oaks Venture Capital
51 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (24%), Enterprise Software (20%), Fintech (18%).
See Great Oaks Venture Capital's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Immuto Scientific and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Gravity Fund adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/immutotherapeutics.com/investors
# also
GET /v1/companies/immutotherapeutics.com
GET /v1/companies/immutotherapeutics.com/news